Literature DB >> 11386316

Angiotensin-II-receptor inhibitors in pregnancy.

N A Chung, G Y Lip, M Beevers, D G Beevers.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11386316     DOI: 10.1016/S0140-6736(00)04759-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Taking ACE inhibitors during pregnancy. Is it safe?

Authors:  Savithiri Ratnapalan; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-06       Impact factor: 3.275

Review 2.  Hypertension in pregnancy.

Authors:  Maryann Mugo; Gurushankar Govindarajan; L Romayne Kurukulasuriya; James R Sowers; Samy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.

Authors:  Chisa Shimada; Rina Akaishi; Kazutoshi Cho; Mamoru Morikawa; Yosuke Kaneshi; Takahiro Yamda; Hisanori Minakami
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

5.  Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Authors:  E Boix; P Zapater; A Picó; O Moreno
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

6.  Losartan induced fetal toxicity.

Authors:  Bonilla Nayar; Ashwani Singhal; Rajiv Aggarwal; Neena Malhotra
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

7.  The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.

Authors:  Myla E Moretti; Daniela Caprara; Irina Drehuta; Emily Yeung; Stefanie Cheung; Lisa Federico; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2011-12-13

8.  Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: a case report and review of the literature.

Authors:  Eleni Georgaki-Angelaki; Nicolaos Stergiou; Ekaterini Naoum; Ioannis Papassotiriou; Marina Anagnostakou
Journal:  NDT Plus       Date:  2009-04-22

9.  Placental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in rats.

Authors:  Tae Hwan Kim; Min Gi Kim; Soyoung Shin; Yong-Ha Chi; Soo-Heui Paik; Joo-Han Lee; Sun Dong Yoo; Yu Seok Youn; Jürgen B Bulitta; Sang Hoon Joo; Seok Won Jeong; Kwon-Yeon Weon; Beom Soo Shin
Journal:  BMC Pharmacol Toxicol       Date:  2016-07-26       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.